Image Credit: STAT News
STAT+: Eli Lilly’s Alzheimer’s drug gets thumbs down from European regulators
Eli Lilly's Kisunla was approved in the U.S. for Alzheimer's last year, but now advisers to the European Medicines Agency say it shouldn't be approved.